Items where Author or Contributor is "Godec, Thomas R"
 | Up a level |
Jump to: Article
Number of items: 5.
Article
Casley, Lucy S;
Godec, Tom;
Logan, James G;
Pearce, James C;
Smith, Hugh MP;
Stewart, Sophie A;
Dewhirst, Sarah Y;
(2018)
How clean is your house? A study of house dust mites, allergens and other contents of dust samples collected from households.
International journal of environmental health research, 28 (4).
pp. 341-357.
ISSN 0960-3123
DOI: https://doi.org/10.1080/09603123.2018.1457141
Full text not available from this repository.
Gupta, Ajay;
Godec, Tom;
Sever, Peter;
(2017)
Concerns related to the nocebo effect - Authors' reply.
Lancet, 390 (10105).
1832-.
ISSN 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(17)32423-6
Gupta, Ajay;
Mackay, Judith;
Whitehouse, Andrew;
Godec, Thomas;
Collier, Tim;
Pocock, Stuart;
Poulter, Neil;
Sever, Peter;
(2018)
Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
Lancet, 392 (10153).
pp. 1127-1137.
ISSN 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(18)31776-8
Khunti, Kamlesh;
Godec, Thomas R;
Medina, Jesús;
Garcia-Alvarez, Laura;
Hiller, Josh;
Gomes, Marilia B;
Cid-Ruzafa, Javier;
Charbonnel, Bernard;
Fenici, Peter;
Hammar, Niklas;
+6 more...
Hashigami, Kiyoshi;
Kosiborod, Mikhail;
Nicolucci, Antonio;
Shestakova, Marina V;
Ji, Linong;
Pocock, Stuart;
(2017)
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
Diabetes, obesity & metabolism, 20 (2).
pp. 389-399.
ISSN 1462-8902
DOI: https://doi.org/10.1111/dom.13083
Wilding, John;
Godec, Thomas;
Khunti, Kamlesh;
Pocock, Stuart;
Fox, Robin;
Smeeth, Liam;
Clauson, Per;
Fenici, Peter;
Hammar, Niklas;
Medina, Jesús;
(2018)
Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research Datalink.
BMC medicine, 16 (1).
116-.
ISSN 1741-7015
DOI: https://doi.org/10.1186/s12916-018-1085-8